-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Cardiac injury in patients with COPD presenting with dyspnea: a pilot study
Case Series
(1762) Views (489) Full article downloads
Authors: Esosa Odigie-Okon, Bryan Jordan, Sylvester Dijeh, et al
Published Date November 2010
Volume 2010:5 Pages 395 - 399
DOI: http://dx.doi.org/10.2147/COPD.S11975
Esosa Odigie-Okon, Bryan Jordan, Sylvester Dijeh, Armand Wolff, Razvan Dadu, Priyanka Lall, Stuart Zarich, Yaw Amoateng-Adjepong, Constantine A ManthousBridgeport Hospital and Yale University School of Medicine, Bridgeport, CT, USA
Purpose: The aim of this pilot study was to test the hypothesis that myocardial ischemia complicates the management of some patients with chest-pain-free chronic obstructive pulmonary disease (COPD) exacerbations.
Methods: In this prospective, observational, cohort study, patients admitted to a 350-bed community teaching hospital, with dyspnea and a primary diagnosis of COPD exacerbation, were followed for enzymatic and electrocardiographic evidence of myocardial ischemia for the first 24 hours of hospital admission.
Results: A total of 114 patients were studied. Overall, four patients had definite myocardial infarctions, one had definite myocardial ischemia and 14 had possible myocardial ischemia. In multiple logistic regression models, age, number of coronary risk factors, and amount of administered albuterol were not associated with myocardial injury.
Conclusion: While unrecognized myocardial injury is relatively rare in patients with an exacerbation of COPD, it occurs frequently enough to warrant some caution since beta-agonists are the mainstays of therapy.
Keywords: COPD, myocardial ischemia, acute coronary syndrome, troponin
Readers of this article also read:
COPD is frequent in conditions of comorbidity in patients treated with various diseases in a university hospital
Budesonide/formoterol combination in COPD: a US perspective
Development and implementation of treadmill exercise testing protocols in COPD
Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors
Improving adherence with inhaler therapy in COPD
In search of parsimony: reliability and validity of the Functional Performance Inventory-Short Form
Association between lung function and exacerbation frequency in patients with COPD
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




